Susan Anderson Jones, MD
Interventional Pain Medicine · Liberty, MONPI 1932182763
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Medtronic at 59.3% of the total. 2025 is the largest year on record at $1,099, 3.9 times the $281 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in MO, where the typical reported total is $2,673.
Across 20 payments — averaging $91.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- SPR Therapeutics, Inc$362
- Stimwave Technologies Incorporated$123
- Boston Scientific$91
- Pfizer$63
- Collegium Pharmaceutical, Inc.$58
- plus $48 from 2 others
What the payments were for
- Travel & lodging$95652%
- Food & beverage$87548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $1,086 |
| SPR Therapeutics, Inc | 5 | $362 |
| Stimwave Technologies Incorporated | 1 | $123 |
| Boston Scientific | 5 | $91 |
| Pfizer | 1 | $63 |
| Collegium Pharmaceutical, Inc. | 1 | $58 |
| Nevro Corp. | 1 | $26 |
| Avanos Medical | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,831 in reported general payments places this provider in the 35th percentile of 27 interventional pain medicine providers in Missouri.
See all interventional pain medicine providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 26 | $1,302 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $1,277 |
| Oxycodone Hcl | 13 | $261 |
| Gabapentin | 13 | $195 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $180 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $160 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Liberty
- Rebecca SandersJoplin$209K
- Ramis GheithBridgeton$73K
- Helen BlakeChesterfield$48K
- Andrew FrazierKansas City$32K
- Christian OliverBridgeton$18K
- David TonkinSpringfield$14K
- Dwayne JonesKansas City$11K
- Bradford NobleColumbia$8K
- Calvin CajigalDes Peres$8K
- James NewtonColumbia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.